Hoppa till innehållet

Redeye: TH1NG - A pivotal 2024 ahead

Redeye revises our forecast following TH1NG’s Q4 2023 report. We find the robust approximately 40% year-on-year and quarter-on-quarter growth encouraging, and TH1NG reaffirms its financial target to achieve positive cash flow by the end of 2024. Our base case remains intact at SEK4.0, while our new fair value range is SEK0.5-SEK9.8.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera